These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 37935069)

  • 1. The impacts of CYP3A4 genetic polymorphism and drug interactions on the metabolism of lurasidone.
    Li Q; Wang J; Wang ZL; Shen Y; Zhou Q; Liu YN; Hu GX; Cai JP; Xu RA
    Biomed Pharmacother; 2023 Dec; 168():115833. PubMed ID: 37935069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of drug-drug interactions and CYP3A4 variants on alectinib metabolism.
    Liu YN; Chen J; Wang J; Li Q; Hu GX; Cai JP; Lin G; Xu RA
    Arch Toxicol; 2023 Aug; 97(8):2133-2142. PubMed ID: 37209178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of CYP3A4 genetic polymorphism and drug interaction on the metabolism of istradefylline.
    Hu X; Ni J; Gao N; Ye Z; Hu G; Cai J; Qian J
    Chem Biol Interact; 2022 Oct; 366():110123. PubMed ID: 36007633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of Resveratrol on the pharmacokinetic profile of tofacitinib and the underlying mechanism.
    Ye Z; Hu J; Wang J; Liu YN; Hu GX; Xu RA
    Chem Biol Interact; 2023 Apr; 374():110398. PubMed ID: 36773832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Influence of CYP3A4 Genetic Polymorphism and Proton Pump Inhibitors on Osimertinib Metabolism.
    Gao N; Zhang X; Hu X; Kong Q; Cai J; Hu G; Qian J
    Front Pharmacol; 2022; 13():794931. PubMed ID: 35359868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of flavonoids and CYP3A4 variants on midostaurin metabolism.
    Xu RA; Li QQ; Gao NY; Wang J; Li XY; Ye F; Ni JH; Hu GX; Qian JC
    Food Chem Toxicol; 2023 Apr; 174():113669. PubMed ID: 36805545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of the effects of axitinib on the pharmacokinetics of loperamide and its main metabolite N-demethylated loperamide in rats by UPLC-MS/MS.
    Lin QM; Pang NH; Li YH; Huang HL; Zhang XD; Hu GX; Wang ZS
    Chem Biol Interact; 2019 Sep; 310():108744. PubMed ID: 31299239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vitro metabolism of glycyrrhetinic acid by human and rat liver microsomes and its interactions with six CYP substrates.
    Zhao K; Ding M; Cao H; Cao ZX
    J Pharm Pharmacol; 2012 Oct; 64(10):1445-51. PubMed ID: 22943175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional evaluation of cyclosporine metabolism by CYP3A4 variants and potential drug interactions.
    Kong Q; Gao N; Wang Y; Hu G; Qian J; Chen B
    Front Pharmacol; 2022; 13():1044817. PubMed ID: 36686709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional evaluation of vandetanib metabolism by CYP3A4 variants and potential drug interactions in vitro.
    Han M; Zhang X; Ye Z; Wang J; Qian J; Hu G; Cai J
    Chem Biol Interact; 2021 Dec; 350():109700. PubMed ID: 34648813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variations of CYP3A4 on the metabolism of itraconazole in vitro.
    Xie SL; Zhu X; Gao N; Lin Q; Chen C; Yang YJ; Cai JP; Hu GX; Xu RA
    Food Chem Toxicol; 2023 Nov; 181():114101. PubMed ID: 37863381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effect of resveratrol on the pharmacokinetic of ibrutinib by UPLC-MS/MS.
    Wen J; Bao SS; Zhang BW; Liu TH; Ou-Yang QG; Cai JP; Zhou HY
    Drug Dev Ind Pharm; 2019 Jan; 45(1):27-31. PubMed ID: 30156133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene Polymorphisms and Drug-Drug Interactions Determine the Metabolic Profile of Blonanserin.
    Ye F; Li X; Ni J; Xu X; Luo J; Zhong Y; Wang Y; Wang S; Zhang Y; Hu G; Qian J
    J Pharmacol Exp Ther; 2024 Jan; 388(1):190-200. PubMed ID: 37863485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the inhibitory effect of isavuconazole on flumatinib metabolism
    Liu YN; Xu X; Nie J; Hu Y; Xu X; Xu RA; Du X
    Front Pharmacol; 2023; 14():1168852. PubMed ID: 37214442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of CYP3A4 and CYP3A5 catalyzed metabolism of alprazolam and quinine by ketoconazole as racemate and four different enantiomers.
    Allqvist A; Miura J; Bertilsson L; Mirghani RA
    Eur J Clin Pharmacol; 2007 Feb; 63(2):173-9. PubMed ID: 17200836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional Measurement of CYP2C9 and CYP3A4 Allelic Polymorphism on Sildenafil Metabolism.
    Tang PF; Zheng X; Hu XX; Yang CC; Chen Z; Qian JC; Cai JP; Hu GX
    Drug Des Devel Ther; 2020; 14():5129-5141. PubMed ID: 33262574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of 27 CYP3A4 protein variants on saxagliptin metabolism in vitro.
    Liu Q; Ou-Yang QG; Lin QM; Lu XR; Ma YQ; Li YH; Xu RA; Lin DD; Hu GX; Cai JP
    Fundam Clin Pharmacol; 2022 Feb; 36(1):150-159. PubMed ID: 33961299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional characterization of 27 CYP3A4 protein variants to metabolize regorafenib in vitro.
    Li YH; Lin QM; Pang NH; Zhang XD; Huang HL; Cai JP; Hu GX
    Basic Clin Pharmacol Toxicol; 2019 Oct; 125(4):337-344. PubMed ID: 31058459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The atypical neuroleptics iloperidone and lurasidone inhibit human cytochrome P450 enzymes in vitro. Evaluation of potential metabolic interactions.
    Danek PJ; Wójcikowski J; Daniel WA
    Pharmacol Rep; 2020 Dec; 72(6):1685-1694. PubMed ID: 32279279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro metabolism of carbofuran by human, mouse, and rat cytochrome P450 and interactions with chlorpyrifos, testosterone, and estradiol.
    Usmani KA; Hodgson E; Rose RL
    Chem Biol Interact; 2004 Dec; 150(3):221-32. PubMed ID: 15560889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.